Confident Investing Starts Here:
- Easily unpack a company's performance with TipRanks' new KPI Data for smart investment decisions
- Receive undervalued, market resilient stocks right to your inbox with TipRanks' Smart Value Newsletter
Regeneus Ltd. ( (AU:CMB) ) has shared an announcement.
Cambium Bio Limited has announced the appointment of Chandra Bala as a new director, effective November 22, 2024. The notice submitted to the ASX outlines that Bala currently holds no relevant interests in securities or contracts within the company, indicating a fresh start in his role. This announcement signifies a potential strategic move for Cambium Bio Limited, possibly impacting its governance structure and signaling a new phase in its leadership dynamics.
More about Regeneus Ltd.
YTD Price Performance: -5.00%
Average Trading Volume: 10,548
Technical Sentiment Consensus Rating: Buy
Current Market Cap: A$5.37M
See more insights into CMB stock on TipRanks’ Stock Analysis page.